Moon Surgical
Moon Surgical is a Paris-based surgical robotics company developing the Maestro System, a collaborative robotic platform with AI capabilities for laparoscopic procedures. The company serves hospitals, surgical centers, and ambulatory surgery centers across the US and Europe, having treated more than 2,300 patients to date.
- Company typePrivate
- Founded2020
- HeadquartersParis, France
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Moon Surgical does
Moon Surgical is a Paris-based surgical robotics company, founded in 2020 (originally as MastOR), that develops the Maestro System, a collaborative and adaptive robotic platform designed to assist surgeons during laparoscopic and minimally invasive procedures. The system features gravity-defying robotic arms that operate without clutching or foot pedals, and is engineered to be compatible with standard off-the-shelf 5mm and 10mm instruments from any manufacturer - a deliberate departure from the proprietary-consumable model used by incumbent surgical robotics platforms. The Maestro platform is FDA-cleared (initial 510(k) in December 2022, commercial version in June 2024) and CE-marked (April 2023), and is sold to hospitals, surgical centers, and ambulatory surgery centers performing general, bariatric, gynecologic, and urologic procedures.
The platform's differentiation rests on integrated AI capabilities built on NVIDIA Holoscan technology. ScoPilot, FDA-cleared in March 2025, is the first AI application to run intraoperatively on any commercially available surgical robotic platform, providing automatic laparoscope positioning that frees the surgeon's hands. The platform evolved in June 2026 with Maestro Software Version 2.7 into a multi-model Physical AI system introducing Automated Setup (physical AI for platform positioning), enhanced ScoPilot (intraoperative assistance), and Automated Operative Reports (via third-party AI integration), along with a 40% boot-time reduction and Mobile Standby Mode. A July 2025 FDA clearance added Wi-Fi/5G connectivity and a Predetermined Change Control Plan for ScoPilot, enabling cloud-to-edge AI feature deployment. A growing dataset of 3,000+ procedures (as of June 2026) powers the system's AI capabilities, supported by ISO 27001 and SOC 2 certifications for data security.
Moon Surgical employs a direct enterprise field sales model, supplemented by a mobile demo truck that brings hands-on Maestro demonstrations to hospitals. Pricing is not publicly disclosed but is structured as a multi-year contract that bundles the hardware, consumables, and ongoing software updates in a single cost - a transparent-pricing positioning relative to incumbents. As of December 2025, more than 2,300 patients had been treated across the US and Europe at named institutions including Lee Health's Gulf Coast Medical Center (Florida, 100+ procedures), Polyclinique de Franche-Comté (France), Arnault Tzanck Institute (France), CHU Saint-Pierre (Belgium, First-in-Human study), and Surgeon's Point Surgery Center (ASC setting). The company has raised approximately $86.7M+ across seed (2020, Sofinnova MD Start), Series A ($31.3M, May 2022, led by GT Healthcare Capital & Partners with Johnson & Johnson Innovation and Cathay Health), and Series B ($55.4M, May 2023, co-led by Sofinnova Partners and NVIDIA's NVentures).
Moon Surgical firmographics
Firmographics- Name
- Moon Surgical
- Legal name
- Moon Surgical
- Website
- https://moonsurgical.com
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Moon Surgical is a Paris-based surgical robotics company developing the Maestro System, a collaborative robotic platform with AI capabilities for laparoscopic procedures. The company serves hospitals, surgical centers, and ambulatory surgery centers across the US and Europe, having treated more than 2,300 patients to date.
- Ownership category
- akta.pro rank
Moon Surgical industry classification
Industry- Product category
- Surgical Robotics
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Surgical Robotics & Computer-Assisted Surgery Platforms (HLAHADAF)
- akta.pro secondary industries
- Operating Room Integration & Surgical Informatics (OR control, documentation, connectivity) (HLAHADAE), Healthcare & Assistive Robotics (HDAAAIAC)
Keywords
Where Moon Surgical is headquartered
LocationHeadquarters
- HQ city
- Paris
- HQ country
- France
- HQ region
- Europe
Offices2 records
Markets served
Moon Surgical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Marketing or Sales, Personnel, Operations, Infrastructure
Revenue model
- Maestro System (Robotic Hardware): Sale or placement of the Maestro surgical robotic system to hospitals and surgical centers. The system is designed for seamless integration into existing OR workflows.
- Consumables and Instruments: Revenue from compatible surgical instruments and consumables used with the Maestro system. The business model includes all consumables in one straightforward cost.
- Software Updates and Upgrades: Ongoing software updates and AI feature enhancements (e.g., ScoPilot, Maestro Insights) deployed across the installed base via cloud connectivity.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Maestro System - Commercial |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels5 records
Moon Surgical product offering
Product offeringCore offering
Moon Surgical develops and sells the Maestro System, a collaborative and adaptive robotic surgical assistant platform that supports surgeons during laparoscopic and minimally invasive procedures. The system features gravity-defying arms compatible with off-the-shelf 5mm and 10mm instruments, requires no clutching or foot pedals, and offers same-day training with a 3-5 procedure learning curve. The company complements the hardware with AI-powered software features (ScoPilot, Maestro Insights) powered by NVIDIA Holoscan technology.
Product overview
Moon Surgical offers the Maestro™ System as its core surgical robotics platform for laparoscopic procedures, accompanied by the Maestro Insights cloud analytics add-on module and the ScoPilot AI-powered laparoscope control feature. The Maestro platform provides a digitalized operating room with intelligent robotic arms that understand when to lock and unlock without clutching or foot pedals. The system integrates with standard 5mm and 10mm instruments. The product portfolio includes the cloud-based Maestro Insights platform for procedural analytics and administrative tools, and ScoPilot for AI-driven intraoperative assistance. The platform received initial FDA clearance in December 2022, commercial FDA clearance in June 2024, and CE Mark in September 2023, with Software Version 2.7 released in June 2026 adding multi-model Physical AI capabilities.
Differentiator
Problem solved
Functional benefit
Brands
- Maestro: Surgical robotic assistance platform for laparoscopic surgery
- Maestro Insights
- ScoPilot
- Maestro System
Products and services
- Maestro System A surgical robotic assistance platform for laparoscopic and minimally invasive procedures that provides gravity-defying robotic arms for camera tracking and tissue exposure. Features same-day training, a 3-5 procedure learning curve, and compatibility with standard off-the-shelf 5mm and 10mm instruments. Requires no clutching or foot pedals. Available in US and EU markets following FDA clearance (December 2022, June 2024) and CE Mark (September 2023).
- Maestro Insights A cloud-based analytics platform that delivers procedural metrics, OR operational insights, and automated administrative tools for the Maestro System. Includes workflow optimization features for staff efficiency, continuous analysis for surgical quality enhancement, measured performance tracking, and cost control with transparent pricing. Powered by NVIDIA technology and enabled by edge-to-cloud connectivity across the installed base.
- ScoPilot An AI-powered feature on the Maestro System that enables automatic laparoscope positioning during surgery using NVIDIA Holoscan technology. Provides real-time sensing, stable surgical visualization, and enhanced control by using the instruments being held to control the laparoscope, freeing the surgeon's hands while improving ergonomics.
- Maestro Software Version 2.7 A multi-model Physical AI platform update expanding the Maestro System from single AI capability to coordinated AI-driven features across the surgical workflow. Includes Automated Setup with physical AI positioning, enhanced ScoPilot intraoperative assistance with expanded clinical datasets, and Automated Operative Reports via third-party AI integration. Adds 40% boot time reduction and Mobile Standby Mode for rapid room-to-room transfer.
Quantifiable outcome
- Over 2,300 patients treated across the US and Europe as of December 2025, with zero adverse events reported at Lee Health
- +5 more outcomes
Companies that use Moon Surgical
Customer profileNamed customers5 records
Segments3 records
Ideal customer profiles3 records
Moon Surgical technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability9 records
Feature6 records
Moon Surgical partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- King's College LondoncoreStrategic partnership announced March 2021 to develop machine learning for computer-assisted surgery. Combines academic research capabilities with Moon Surgical's robotic platform development.
Scale indicators6 records
Recent moves6 records
Expansion highlights6 records
Moon Surgical competitors and assessment
Company assessmentDirect peers
- Intuitive Surgical: Creator of the da Vinci surgical system, the dominant soft-tissue surgical robotics platform globally. Moon Surgical's board includes Intuitive's founder Fred Moll, and Maestro directly competes for the same laparoscopic soft-tissue procedures da Vinci has historically monopolized.
- CMR Surgical: UK-based developer of the Versius Surgical System, a modular, portable soft-tissue surgical robot designed for laparoscopic procedures. Versius targets the same value proposition of accessibility and lower total cost that Moon Surgical is pursuing with Maestro.
Broad incumbents
- Medtronic: Developer of the Hugo robotic-assisted surgery system, a multi-port soft-tissue surgical robot. Hugo is one of the most credible competitive entrants to da Vinci and competes directly with Maestro in laparoscopic general surgery globally.
- Johnson & Johnson (Ottava): J&J is developing the Ottava general surgery robotic platform while simultaneously being a strategic investor in Moon Surgical via J&J Innovation. Their potential entry is a competitive threat to Maestro and a sign of the incumbent's strategic interest in Moon Surgical's differentiated architecture.
- Stryker (Mako): Stryker's Mako robotic system is the dominant orthopedic surgical robot. While Mako targets orthopedic procedures rather than soft-tissue laparoscopy, Stryker is a relevant broad incumbent demonstrating how an orthopedic-focused robot can scale into a multibillion-dollar franchise.
Emerging players
- Asensus Surgical: Developer of the Senhance surgical system, a digital laparoscopy platform with machine-vision and AI capabilities for soft-tissue surgery. Comparable as an emerging alternative in laparoscopic robotic surgery with a similar digital-surgery thesis.
- Vicarious Surgical: Developer of a single-port robotic surgical system for abdominal procedures. Comparable as a venture-backed surgical robotics company targeting laparoscopic soft-tissue surgery with a differentiated human-like robotic architecture.
- PROCEPT BioRobotics: Developer of the Aquablation and HYDROS robotic systems for urology. Comparable as a venture-backed surgical robotics company that has scaled to commercialization and public markets, often cited as a peer for surgical robotics investors.
- Activ Surgical: Developer of an AI-powered surgical visualization and intraoperative intelligence platform. Comparable as a surgical AI company with a focus on real-time intraoperative AI analogous to Moon Surgical's ScoPilot feature.
- Noah Medical: Developer of the Galaxy System, a robotic platform for navigated bronchoscopy. Comparable as a venture-backed robotic surgery company that has reached commercialization with FDA clearance, addressing a specific procedural niche.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat6 records
Key risks6 records
Key highlights6 records
Customer concentration
Moon Surgical social profiles
Digital presenceMoon Surgical compliance and trust
Trust signalCompliance4 records
Moon Surgical financial estimates
Financial estimateRevenue estimate
Valuation estimate
Moon Surgical leadership team
Management profileNumber of profiles
Profiles18 records
Moon Surgical funding detail
Funding detailFunding overview
Funding rounds7 records
Investors11 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Moon Surgical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Moon Surgical
What does Moon Surgical do?
Moon Surgical develops and sells the Maestro System, a collaborative and adaptive robotic surgical assistant platform that supports surgeons during laparoscopic and minimally invasive procedures. The system features gravity-defying arms compatible with off-the-shelf 5mm and 10mm instruments, requires no clutching or foot pedals, and offers same-day training with a 3-5 procedure learning curve. The company complements the hardware with AI-powered software features (ScoPilot, Maestro Insights) powered by NVIDIA Holoscan technology.
Is Moon Surgical a public or private company?
Moon Surgical is a private company. It is classified as venture growth investor backed and is currently operating.
When was Moon Surgical founded?
Moon Surgical was founded in 2020. It employs 101 to 250 people.
Where is Moon Surgical based?
Moon Surgical is headquartered in Paris, France, in the Europe region.
How does Moon Surgical make money?
Three revenue lines are on record. Maestro System (Robotic Hardware) is the primary driver. The others are consumables and Instruments and software Updates and Upgrades.
Who are Moon Surgical's main competitors?
Direct peers on record are Intuitive Surgical and CMR Surgical. Broad incumbents are Medtronic, Johnson & Johnson (Ottava) and Stryker (Mako). Emerging players are Asensus Surgical, Vicarious Surgical, PROCEPT BioRobotics, Activ Surgical and Noah Medical.
Does Moon Surgical have an API?
No public API is recorded for Moon Surgical.
What industry is Moon Surgical in?
Moon Surgical's product category is Surgical Robotics. Its primary akta.pro industry code is HLAHADAF, Surgical Robotics & Computer-Assisted Surgery Platforms, with a secondary code of HLAHADAE, Operating Room Integration & Surgical Informatics (OR control, documentation, connectivity). Its NAICS code is 339112 and its SIC code is 3841.